TNF Inhibitors and Risk of Serious Infection in Pregnancy
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
TNF Inhibitors and Risk of Serious Infection in Pregnancy
-
Narrated by:
-
Written by:
About this listen
In this episode, we sit down with Dr. Evelyne Vinet about a new study examining whether TNF inhibitors increase the risk of serious infections during pregnancy among women with chronic inflammatory diseases. Using large real-world data from the MarketScan database, the discussion explores how pregnancy, inflammatory disease, TNF inhibitor exposure, and serious infections were defined, how confounders were addressed, and what the data reveal across pregnancy and the postpartum period. Dr. Vinet also reflects on study limitations, the impact of COVID-19, and her broader work on pregnancy outcomes and long-term child health in rheumatic diseases, offering insights for clinicians and researchers alike.
Tumor Necrosis Factor Inhibitors and Risk of Serious Infections in Pregnant Women With Chronic Inflammatory Diseases